The Technical Analyst
Direxion Daily Healthcare [CURE]
Exchange: NYSE
Direxion Daily Healthcare Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.92% $109.73
America/New_York / 8 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 182.49 mill |
| EPS: | 4.29 |
| P/E: | 25.59 |
| Earnings Date: | N/A |
| SharesOutstanding: | 1.663 mill |
| Avg Daily Volume: | 0.0379 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.07x |
| Company: PE 25.59 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.89x |
| Company: PE 25.59 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 106.28 - 113.18 ( +/- 3.15%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2006-04-13 | Maudlin Timothy I | Sell | 54 374 | Common Stock |
| 2006-04-13 | Maudlin Timothy I | Sell | 5 595 | Common Stock |
| 2006-04-13 | Maudlin Timothy I | Sell | 10 685 | Common Stock |
| 2005-12-19 | Axmacher Thomas | Sell | 2 120 | Common Stock |
| 2005-12-21 | Axmacher Thomas | Sell | 20 000 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 26 transactions |
| Buy: 110 700 | Sell: 220 449 |
Forecast:
16:00 - $109.73
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $109.73
Forecast 2: 16:00 - $109.73
Forecast 3: 16:00 - $109.73
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $109.73 (-0.92% ) |
| Volume | 0.0213 mill |
| Avg. Vol. | 0.0379 mill |
| % of Avg. Vol | 56.17 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CURE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CURE
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Latest News
2024-02-28 10:25:50 - ETF Trends
Healthcare Showing That Big Tech Isn't the Only Bull in Town
While capital markets are seemingly fixated on the astounding returns of big tech and the growth prospects of artificial intelligence (AI), the sector isn't the only bull in town. The healthcare sector is also outperforming and shouldn't be overlooked by long- and short-term investors.
2024-01-17 14:00:00 - Seeking Alpha
JD Henning Cautious About 2024, An Unusual Year For Market Considerations
JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios.
2023-12-20 13:04:48 - ETF Trends
AI Adoption in Healthcare Spells Opportunity in 2 ETFs
Traders eyeing potential plays in the new year may want to look at the healthcare sector given its growing adoption of artificial intelligence (AI). Technological advancement in healthcare should spell opportunities in the Direxion Daily Healthcare Bull 3X ETF (CURE) and the Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X ETF (UBOT).
2023-11-28 13:04:51 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 11/26/2023
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2023-11-27 14:17:09 - Zacks Investment Research
Best Inverse/Leveraged ETFs of Last Week
2023-11-16 12:25:19 - Seeking Alpha
Healthcare Dashboard, And The Side Effects Of CURE
Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper than their peers in November.
2023-07-25 14:33:04 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 07/23/2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2023-07-24 09:20:20 - Zacks Investment Research
5 Best Inverse/Leveraged ETF Areas of Last Week
Wall Street delivered a mixed performance last week due to the steepening of the yield curve.
2023-07-17 06:51:13 - Seeking Alpha
July Breakout ETF/ETNs Week 29 - 2023: Strongest Momentum Gainers For Next Week
This article highlights current and future ETF/ETN breakouts for Week 29 using the MDA momentum cycle model. Following the positive Momentum Gauge signal on June 1st, leading funds include NAIL +67.1%, FNGU +27.5%, TNA +26.5%, BNKU +20.5%, SPXL +19.5%, FAS +19.4%. Healthcare remains the only sector negative for the past month, and the beat by UnitedHealth Group may lead to a breakout in Healthcare fund CURE.
2023-07-11 12:11:15 - Seeking Alpha
CURE: One Of Those Rare 3x Leveraged ETFs That Has Delivered Long-Term Returns
IXVTR has been one of the best-performing healthcare indices. Investments in a 3x leveraged ETF benchmarking IXVTR can thus provide attractive returns. CURE has been one of those rare 3x leveraged ETFs that generated consistent returns not only during short runs, but over a much longer time horizon, too. CURE's major investments have delivered positive price growth over the past 12 years of its existence. Its 3x investments too delivered 29 percent returns.